Cargando…

Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID‐19 pneumonia

Detalles Bibliográficos
Autores principales: Zurita‐Lizza, Christian Carlos, Doreski, Pablo Alexis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087023/
https://www.ncbi.nlm.nih.gov/pubmed/35572363
http://dx.doi.org/10.1002/ctd2.31
_version_ 1784704129492320256
author Zurita‐Lizza, Christian Carlos
Doreski, Pablo Alexis
author_facet Zurita‐Lizza, Christian Carlos
Doreski, Pablo Alexis
author_sort Zurita‐Lizza, Christian Carlos
collection PubMed
description
format Online
Article
Text
id pubmed-9087023
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90870232022-05-10 Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID‐19 pneumonia Zurita‐Lizza, Christian Carlos Doreski, Pablo Alexis Clin Transl Discov Letter to the Editor John Wiley and Sons Inc. 2022-02-20 2022-03 /pmc/articles/PMC9087023/ /pubmed/35572363 http://dx.doi.org/10.1002/ctd2.31 Text en © 2022 The Authors. Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Zurita‐Lizza, Christian Carlos
Doreski, Pablo Alexis
Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID‐19 pneumonia
title Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID‐19 pneumonia
title_full Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID‐19 pneumonia
title_fullStr Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID‐19 pneumonia
title_full_unstemmed Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID‐19 pneumonia
title_short Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID‐19 pneumonia
title_sort potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in covid‐19 pneumonia
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087023/
https://www.ncbi.nlm.nih.gov/pubmed/35572363
http://dx.doi.org/10.1002/ctd2.31
work_keys_str_mv AT zuritalizzachristiancarlos potentialreversalofpulmonaryvasoplegiabyinhaledibuprofenateincovid19pneumonia
AT doreskipabloalexis potentialreversalofpulmonaryvasoplegiabyinhaledibuprofenateincovid19pneumonia